Trademark Logo
Application Number:5023187
Status:
Unknown
Class:5
Filing Date:Tue, 29 Jun 2021
In Progress

Is this your trademark application?

"NEXAPARIN-40" is still moving through the registration pipeline. Most applications hit at least one hurdle — objection, opposition or a hearing — and deadlines at each stage are short. Get notified the moment the status changes.

Get free status guidance

+91

Trademark Information

TrademarkNEXAPARIN-40
Trademark TypeWordmark
Class5
Application Number5023187
Nature/Scope of businessPHARMACEUTICAL PRODUCTS FOR MEDICAL USE
PublicationIn Journal No. 2136
Status
Unknown
Applicant: M/S NIXI LABORATORIES PVT LTD.
Applicant AddressV.P.O. MAUZA OGLI, SADHORA ROAD, KALA AMB, HIMACHAL PARDESH BODY INCORPORATE
JurisdictionDELHI
AgentHITESH LALIT
Agent AddressH.No- 444, NEW KARTARPURA, BEHIND MADHU COLONY, YAMUNANAGAR, HARYANA-135001

Frequently Asked Questions

Who is the owner of trademark NEXAPARIN-40?
The trademark application number 5023187 is owned by M/S NIXI LABORATORIES PVT LTD..
Which class does trademark NEXAPARIN-40 belong to?
Trademark application number 5023187 is filed under Class 5, which relates to the specified goods and services.
Who is the trademark agent for application 5023187?
The trademark agent associated with application number 5023187 is HITESH LALIT.
Was trademark NEXAPARIN-40 published in the journal?
Yes, trademark application number 5023187 was published in Journal No. 2136.
What is trademark NEXAPARIN-40?
Trademark application number 5023187 relates to "PHARMACEUTICAL PRODUCTS FOR MEDICAL USE".

File Trademark at Just ₹1,499 + Govt Fees

Get your trademark registered with expert guidance. Limited time offer!

File Now
Expert Consultation
Quick Processing
100% Support
Free Report

Get Detailed Trademark Report

Comprehensive analysis of your trademark search delivered to your phone

+91

What you'll get:

  • Complete trademark analysis
  • Conflict assessment
  • Registration guidance
15,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified